The Rise In China Deals: How International Biopharma Is Turning To China For Innovation

 
• By Joseph Haas, Mary Jo Laffler, and Nancy Pham
  
China Deals
Dealmaking between Chinese biopharmas and non-Asian firms is taking off (Dancing_Man/Shutterstock)

More from Deal-Making

More from In Vivo